Back to Gastroenterology
Gastroenterologyv1984Evidence-Based

Kruis Score for Diagnosis of Irritable Bowel Syndrome (IBS)

Determines presence of IBS using clinically significant weighted criteria including symptoms and laboratory parameters to differentiate IBS from organic gastrointestinal disease

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
kruis ibs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Kruis Score for Diagnosis of Irritable Bowel Syndrome (IBS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = (+34 if symptoms present) + (+16 if duration >2 years) + (+23 if severe pain) + (+14 if alternating bowel habits) + (-47 if abnormal physical findings) + (-13 if ESR >10) + (-50 if WBC >10,000) + (-98 if low hemoglobin) + (-98 if blood in stool history)

Clinical Pearls & Practice Notes

  • Developed in 1984 by Kruis et al. as one of the first scoring systems for IBS diagnosis
  • Incorporates both positive symptoms and negative red flag indicators
  • Score ≥44 points suggests IBS diagnosis with 81% sensitivity and 91% specificity
  • Red flags (negative points) help exclude organic gastrointestinal disease
  • Has largely been superseded by Rome criteria in clinical practice but remains useful for research
  • Laboratory tests (ESR, WBC, hemoglobin) are integral to the scoring system
  • Originally designed to differentiate IBS from organic bowel disease
  • Emphasizes the importance of symptom duration (>2 years) in IBS diagnosis
  • Any presence of red flags warrants further evaluation for organic pathology

Evidence & Literature Citations

  1. Kruis W, Thieme C, Weinzierl M, Schüssler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology. 1984 Jul;87(1):1-7.
  2. Frigerio G, Beretta A, Orsenigo G, Tadeo G, Imperiali G, Minoli G. Irritable bowel syndrome. Still a diagnosis of exclusion? Dig Dis Sci. 1992 Jan;37(1):164-7.
  3. Bellini M, Tosetti C, Costa F, Biagi S, Stasi C, Del Punta A, et al. The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis. 2005 Dec;37(12):934-9.
  4. Thompson WG. The road to Rome. Gastroenterology. 2006 Nov;131(5):1622-6.

Score Interpretation Ranges

Negative for IBS-305 – 43 pts

Score < 44 points

Positive for IBS44 – 87 pts

Score ≥ 44 points

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.